HIV
Fourth-generation HIV test for earliest possible detection.
Every result includes a professional assessment from a BIG-registered doctor. For treatment decisions, discuss your results with your GP.
The HIV Combo test is a fourth-generation test that detects both HIV p24 antigen and HIV antibodies simultaneously. This dual approach enables earlier detection compared to antibody-only tests, typically within two to six weeks after exposure.
This test simultaneously screens for two markers: the HIV p24 antigen, which is a viral protein produced early in infection, and antibodies that the immune system generates in response to HIV. By detecting both, the test covers different stages of the infection timeline.
The p24 antigen is typically detectable before antibodies develop, which means this combination test can identify HIV infection during the acute phase when viral load is high and transmission risk is greatest.
Early HIV detection is critical for both individual health and public health. Starting antiretroviral therapy promptly after diagnosis can significantly improve long-term health outcomes and reduce the risk of transmitting the virus to others.
With modern treatment, people living with HIV can achieve an undetectable viral load, meaning the virus cannot be transmitted sexually. Early testing is a key step toward accessing this life-changing treatment.
Testing is recommended for anyone who is sexually active, particularly those with new or multiple partners. It is also advised after potential exposure events such as unprotected sexual contact, needle sharing, or occupational exposure.
The window period for this test is typically two to six weeks. For the most reliable results, testing at least four weeks after potential exposure is recommended, with a follow-up test at twelve weeks for definitive confirmation.
Non-reactive result indicates no HIV infection detected. Continue safe practices and regular testing if at risk.
Reactive result requires immediate confirmation testing and consultation with an infectious disease specialist.
Non-reactive result indicates no HIV infection detected. Continue safe practices and regular testing if at risk.
Reactive result requires immediate confirmation testing and consultation with an infectious disease specialist.
Consistent condom use is one of the most effective ways to reduce HIV transmission risk. If you are at higher risk, discuss pre-exposure prophylaxis (PrEP) with your healthcare provider as an additional prevention strategy.
Regular HIV testing normalises screening as part of routine health care. Knowing your status empowers you to make informed decisions about your health and the health of your partners. Never share needles or other injection equipment.
This marker is included in the following test panels.
Fourth-generation HIV test for earliest possible detection.
HIV, Syphilis, and Hepatitis B screening: commonly requested viral and bacterial screenings.